Almirall, LLC is the new name of Aqua Pharmaceuticals. Almirall, LLC is part of the larger Almirall, S.A. family, an internationally-recognized global dermatology pharmaceutical company, with a strong focus on skin health. The name change, was announced jointly by Almirall LLC President and General Manager, Ron Menezes and Almirall, S.A. CEO, Peter Guenter.
"Almirall acquired Aqua at the end of 2013 and both companies have long shared the vision of improving skin health conditions through scientific advances. It was a natural progression for Aqua to assume the Almirall name in the U.S.," explains Menezes. "We want to continue to explore new therapies in dermatology in order to grow and provide new solutions to healthcare professionals and patients."
Guenter adds, "Without question, Aqua established a strong presence in dermatology in the U.S. through delivering quality products and offering effective solutions to dermatologists and their patients. Similarly, Almirall has created a global reputation as a provider of significant medical advances to patients and a commitment to medical dermatology that was shown in the recent acquisition of key brands from the Allergan portfolio. By bringing Aqua under the Almirall name, we are offering healthcare providers and their patients greater and more cohesive support, aligned with our shared resources and innovation in the U.S., as well as globally."
Almirall LLC is launching the campaign "We're all in, we're Almirall,” which the company says speaks to its deep commitment to dermatology. With nearly 14% of sales revenue being invested into research and development by Almirall S.A. in 2017 the company trusts that they are in a strong position to achieve their goal of being a leader of innovation in medical dermatology.